HIV Diagnostics: Current Recommendations and Opportunities for Improvement

Area of Science:

• Clinical diagnostics
• Virology
• Immunology

Background:

• Early human immunodeficiency virus (HIV) diagnostic tests primarily detected immunoglobulin G (IgG) antibodies.
• Technological evolution has led to advanced laboratory testing methods for HIV.
• Current recommendations favor fourth-generation assays for initial HIV screening due to their rapid reactivity.

Purpose of the Study:

• To review the advancements in laboratory testing for human immunodeficiency virus (HIV).
• To discuss the utility of HIV-1 RNA viral load assays in conjunction with initial screening.
• To highlight how early therapeutic interventions can impact biomarker evolution and diagnostic accuracy.

Main Methods:

• Review of technological evolution in HIV immunoassays.
• Discussion of fourth-generation chemiluminescent assay performance.
• Analysis of HIV-1 RNA viral load assay integration for confirmation and clinical information.
• Consideration of the impact of early antiretroviral therapy and pre-exposure prophylaxis on assay results.

Main Results:

• Fourth-generation assays provide rapid detection, becoming reactive as early as two weeks post-infection.
• HIV-1 RNA viral load assays can confirm infection and offer valuable clinical data.
• Early treatment initiation and pre-exposure prophylaxis can influence biomarker expression and assay interpretation.

Conclusions:

• Modern HIV testing has significantly improved early detection capabilities.
• The combination of screening assays and viral load testing enhances diagnostic confirmation and clinical utility.
• Interference from early therapeutic interventions necessitates careful interpretation of HIV test results.